产品中心
当前位置：首页>产品中心Anti-TRIP11/TRIP230/AF555
货号： bs-17131R-AF555 基本售价： 2980.0 元 规格： 100ul
产品信息
- 产品编号
- bs-17131R-AF555
- 英文名称
- Anti-TRIP11/TRIP230/AF555
- 中文名称
- AF555标记的甲状腺激素受体相互作用11抗体
- 别 名
- CEV 14; CEV14; Clonal evolution related gene on chromosome 14; GMAP 210; GMAP210; Golgi associated microtubule binding protein 210; Thyroid hormone receptor interactor 11; Thyroid receptor interacting protein 11; TRIP 11; TRIP 230; TRIP11.
- 规格价格
- 100ul/2980元购买 大包装/询价
- 说 明 书
- 100ul
- 研究领域
- 细胞生物 免疫学 信号转导 表观遗传学
- 抗体来源
- Rabbit
- 克隆类型
- Polyclonal
- 交叉反应
- Human, Mouse, Rat, Pig, Cow, Horse, Rabbit, Sheep,
- 产品应用
- ICC=1:50-200 IF=1:50-200
not yet tested in other applications.
optimal dilutions/concentrations should be determined by the end user.
- 分 子 量
- 238kDa
- 性 状
- Lyophilized or Liquid
- 浓 度
- 1mg/ml
- 免 疫 原
- KLH conjugated synthetic peptide derived from human TRIP11/TRIP230
- 亚 型
- IgG
- 纯化方法
- affinity purified by Protein A
- 储 存 液
- 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol
- 保存条件
- Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C.
- 产品介绍
- background:
TRIP230 was identified through its ability to interact functionally with thyroid hormone receptor-beta. It has also been found in association with the Golgi apparatus and microtubules. TRIP230 binds the ligand binding domain of the thyroid receptor (THRB) in the presence of triiodothyronine and enhances THRB-modulated transcription. This protein is probably involved in maintaining cis-Golgi structure.
Subcellular Location:
Cell Membrane and Golgi Apparatus
Database links:Entrez Gene: 9321Human
Omim: 604505Human
SwissProt: Q15643Human
Unigene: 156892Human
Important Note:
This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.